PSTV Plus Therapeutics Inc Operating Profitability

Official company branding of Plus Therapeutics Inc (PSTV)

Asset volatility for Plus Therapeutics, Inc. (PSTV) is driven by the development of radiotherapy to combat breast and brain tumors. The operating margin curve on the GURU.Markets platform chart shows that the current metric is -364.40. While insurance payments for high-tech treatment provide stability, the lack of recurring revenue due to early-stage drug trials creates typical biotech risks.

PSTV - Plus Therapeutics, Inc. Operating Profit Rate over the range 07/04/2022 - 08/03/2026

Plus Therapeutics Inc - analytical breakdowns and key metrics (PSTV)

- market capitalization data:
Fundamental company analysis:PSTV, Plus Therapeutics Inc
Finished products of Plus Therapeutics

Investors evaluate operational efficiency by analyzing the share of operating profit relative to total EBITDA. For Plus Therapeutics, Inc. (PSTV), whose radiopharmaceuticals are currently in clinical trials without a stable cash flow, the operating profit margin reflects high project development costs and a lack of self-sustaining cash.